PMID- 26200622 OWN - NLM STAT- MEDLINE DCOM- 20151020 LR - 20221005 IS - 1536-5964 (Electronic) IS - 0025-7974 (Print) IS - 0025-7974 (Linking) VI - 94 IP - 29 DP - 2015 Jul TI - Coexistence of Anti-Glomerular Basement Membrane Antibodies and Anti-Neutrophil Cytoplasmic Antibodies in a Child With Human Leukocyte Antigen Susceptibility and Detailed Antibody Description: A Case Report. PG - e1179 LID - 10.1097/MD.0000000000001179 [doi] LID - e1179 AB - Anti-glomerular basement membrane (anti-GBM) disease and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis both could cause rapidly progressive glomerulonephritis. The coexistence of ANCAs and anti-GBM antibodies was known as "double positive," which was extremely rare in children. We report a pediatric case with coexistence of ANCAs and anti-GBM antibodies. A 6-year-old girl presented with acute renal failure, hematuria, proteinuria, and oliguria. She was double positive of ANCAs specific to myeloperoxidase, and anti-GBM antibodies. Kidney biopsy confirmed linear immunoglobulin (Ig)G deposit along GBM and 100% of crescent formation in glomeruli; among them 83.3% were cellular crescents. Human leukocyte antigen (HLA) gene typing showed DRB1*1501, an allele strongly associated with anti-GBM disease, and DRB1*0405, an independent risk factor for renal failure in patients with ANCA-associated vasculitis. The titer of anti-GBM antibodies was 1:800, and the predominant IgG subclass was IgG1, which was closely related with severe kidney injury and worse outcome. The target antigen of anti-GBM antibodies was restricted on the noncollagen domain 1 of the alpha3 chain of type IV collagen (alpha3[IV]NC1), with recognitions to both epitopes, EA (alpha317-31) and EB (alpha3127-141). This is the first reported pediatric case with coexistence of ANCAs and anti-GBM antibodies, in which the HLA typing and immunologic characters of autoantibodies were identified. The findings on this early-onset patient are meaningful for understanding the mechanisms of both anti-GBM disease and ANCA-associated vasculitis. FAU - Xie, Li-Jun AU - Xie LJ AD - From the Renal Division, Department of Medicine, Peking University First Hospital; Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China (L-jX, ZC, X-yJ, M-hZ); Department of Nephrology, Beijing Children's Hospital affiliated to Capital Medical University (ZC, X-rL); Renal Division, Department of Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China (L-jX); and Peking-Tsinghua Center for Life Sciences, Beijing, PR China (M-hZ). FAU - Cui, Zhao AU - Cui Z FAU - Jia, Xiao-Yu AU - Jia XY FAU - Chen, Zhi AU - Chen Z FAU - Liu, Xiao-Rong AU - Liu XR FAU - Zhao, Ming-Hui AU - Zhao MH LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Medicine (Baltimore) JT - Medicine JID - 2985248R RN - 0 (Antibodies, Antineutrophil Cytoplasmic) RN - 0 (Autoantibodies) RN - 0 (HLA Antigens) RN - 0 (Immunoglobulin G) RN - 0 (antiglomerular basement membrane antibody) SB - IM MH - Antibodies, Antineutrophil Cytoplasmic/blood/*immunology MH - Autoantibodies/blood/*immunology MH - Child MH - Female MH - HLA Antigens/genetics MH - Humans MH - Immunoglobulin G/blood MH - Renal Insufficiency/*immunology PMC - PMC4603008 COIS- The authors declare no conflict of interest. EDAT- 2015/07/23 06:00 MHDA- 2015/10/21 06:00 PMCR- 2015/07/24 CRDT- 2015/07/23 06:00 PHST- 2015/07/23 06:00 [entrez] PHST- 2015/07/23 06:00 [pubmed] PHST- 2015/10/21 06:00 [medline] PHST- 2015/07/24 00:00 [pmc-release] AID - 00005792-201507040-00014 [pii] AID - 10.1097/MD.0000000000001179 [doi] PST - ppublish SO - Medicine (Baltimore). 2015 Jul;94(29):e1179. doi: 10.1097/MD.0000000000001179.